Buscar en
Anales de Pediatría Continuada
Toda la web
Inicio Anales de Pediatría Continuada Concepto, clasificación y diagnóstico
Información de la revista
Vol. 1. Núm. 1.
Páginas 15-20 (Enero 2003)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 1. Núm. 1.
Páginas 15-20 (Enero 2003)
DOI: 10.1016/S1696-2818(03)71581-9
Acceso a texto completo
Concepto, clasificación y diagnóstico
Visitas
...
Juan Pedro López-Siguero, Almudena del Pino
Hospital Materno-Infantil. Málaga. España.
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
Group National Diabetes Data.
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
Diabetes, 28 (1979), pp. 1039-1057
[2.]
World Health Organization.
Diabetes mellitus: report of a WHO Study Group, pp. 727
[3.]
J.J. Hoett, B.B. Tripathy, R.H. Rao, C.S. Yajnik.
Malnutrition and diabetes in the tropics.
Diabetes Care, 19 (1996), pp. 1014-1017
[4.]
J. Lu, Q. Li, H. Xie, Z. Chen, A.E. Borovitskaya, Maclaren, et al.
Identification of a second transmembrane protein tyroxine phophatase, IA-2β, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37-kDa tryptic fragment.
Proc Natl Acad Sci USA, 93 (1996), pp. 2307-2311
[5.]
B. Littorin, G. Sundkvist, L. Nystrom, A. Carlson, M. Landin- Olsson, J. Ostman, et al.
Family chacaracteristics and life events before the onset of autoimmune type 1 diabetes in young adults.
Diabetes Care, 24 (2001), pp. 1033-1037
[6.]
T. Kimpimäki, A. Kupila, A.M. Hämäläinen, M. Kukko, P. Kumala, K. Savola, et al.
The first signs of beta-cells autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish type 1 diabetes prediction and prevention study.
J Clin Endocrinol Metab, 86 (2001), pp. 4782-4788
[7.]
Group EURODIAB ACE Study.
Variation and trends in incidence of chilhood diabetes in Europe.
Lancet, 355 (2000), pp. 873-876
[8.]
J.P. López-Siguero, A. Del Pino de la Fuente, M.J. Martínez-Aedo, J.A. Moreno-Molina.
Increased incidence of type 1 diabetes in the south of Spain.
Diabetes Care, 25 (2002), pp. 1099
[9.]
A. Imagawa, T. Hanafusa, J. Miyagawa, Y. Matsuzawa.
A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies.
N Engl J Med, 342 (2000), pp. 301-307
[10.]
S. Tanaka, T. Kobayashi, T. Mornotsu.
Anovel subtype of type 1 diabetes mellitus.
N Engl J Med, 342 (2000), pp. 1835-1837
[11.]
G.R. Vreugdenhil, N.C. Schloot, A. Hoorens, C. Rongen, D.G. Pipeleers, W.J. Melchers, et al.
acute onset of type 1 diabetes mellitus after severe echovirus 9 infection: putative pathogenic pathways.
Clin Infect Dis, 31 (2000), pp. 1025-1031
[12.]
G. Carreras, D. Mauricio, A. Pérez, A. De Leiva.
Can all newly diagnosed subjects without type 1 diabetes-associated autoimmune markers be classified as type 1b diabetics patients?.
Diabetes Care, 23 (2000), pp. 1715-1716
[13.]
S. Tanaka, T. Kobayashi, K. Nakanishi, R. Koyama, M. Okubo, T. Murase, et al.
Association of HLA-DQ genotype in autoantibody- negative and rapid onset type 1 diabetes.
Diabetes Care, 25 (2002), pp. 2302-2307
[14.]
R.R. Wing, E.H. Blair, P. Bononi, M.D. Marcus, R. Watanabe, R.N. Bergman.
Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients.
Diabetes Care, 17 (1994), pp. 30-36
[15.]
G.E. Umpierrez, M.M.C. Casals, S.S.P. Gebhart, P.S. Mizon, L.S. Clark WS Phillips.
Diabetic ketoacidosis in obese African- Americans.
Diabetes, 44 (1995), pp. 79-85
[16.]
A.L. Rosenbloom, J.R. Joe, R.S. Young, W.E. Winter.
Emerginig epidemic of type 2 diabetes in youth.
Diabetes Care, 22 (1999), pp. 345-354
[17.]
S.S. Fajans, G.I. Bell, K.S. Polonsky.
Molecular mechanisms and clinical phatophysiology of maturity-onset diabetes of the young.
N Engl J Med, 27 (2001), pp. 971-980
[18.]
R. Barrio, C. Mellamé-Chantelot, J.C. Moreno, V. Morel, H. Calle, M. Alonso.
Nine novel mutations in maturity-onset diabetes of the young (MODY) candidate genes in 22 Spanish families.
J Clin Endocrinol Metab, 87 (2002), pp. 2532-2539
[19.]
K. Yagamata, H. Furuta, N. Oda.
Mutations in the hepatocyte nuclear factor-4 alfa gene in maturity-onset diabetes of the young (MODY 1).
Nature, 384 (1996), pp. 458-460
[20.]
P. Froguel, H. Zouali, N. Vinnet.
Familial hyperglycemia due to mutations in glucokinase: definition of a subtype of diabetes mellitus.
N Engl J Med, 328 (1993), pp. 697-702
[21.]
K. Yamagata, N. Oda, P.J. Kaisaki.
Mutations in the hepatocyte nuclear factor-1 alfa gene maturity onset diabetes of the young (MODY 3).
Nature, 384 (1996), pp. 455-458
[22.]
L. Bjokaug, J.V. Sagen, P. Thorsby, O. Sovik, A. Molven, P.R. Njolstad.
Hepatocyte nuclear factor-1 alfa gene mutations and diabetes in Norway.
J Clin Endocrinol Metab, (2003), pp. 920-931
[23.]
D.A. Stoffers, J. Ferrer, W.L. Clarke, J.F. Habener.
Early-onset type-II diabetes mellitus (MODY 4) linked to IPF1.
Nat Genet, 17 (1997), pp. 384-385
[24.]
Y. Horikawa, H. Iwasaki, M. Hara.
Mutation in hepatocyte nuclear factor 1-beta gene (TFC2) associated with MODY.
Nat Genet, 17 (1997), pp. 384-385
[25.]
M.T. Malecki, U.S. Jhala, A. Antonellis.
Mutations in NEUROD1 are associated wiiith the development of type 2 diabetes mellitus.
Nat Genet, 23 (1999), pp. 323-328
[26.]
T. Kadowaki, H. Kadowaki, Y. Mori, K. Tobe, R. Sakuta, Y. Suzuki, et al.
A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA.
N Engl J Med, 330 (1994), pp. 962-968
[27.]
D.C. Robbins, S.E. Schoelson, A.H. Rubenstein, H.S. Tafer.
Familial hyperproinsulinemia: two cohorts secreting indistinguishable type II intermediates of proinsulin conversion.
J Clin Invest, 73 (1984), pp. 714-719
[28.]
B.D. Given, M.E. Mako, H.S. Tager, D. Baldwin, J. Markese, A.H. Rubenstein, et al.
Diabetes due to secretion of an abnormal insulin.
N Engl J Med, 302 (1980), pp. 129-135
[29.]
C.S. Yajnik, K.M. Sheldikar, S.S. Naik, S.V. Kanitkar, H. Orskov, K.G.M.M. Alberti, et al.
The ketoacidosis-resistance in fibrocalculous- pancreatic-diabetes.
Diabetes Res Clin Pract, 15 (1992), pp. 149-156
[30.]
M. Berelowitz, H.G. Eugene.
Non-insulin dependent diabetes mellitus secondary to other endocrine disorders.
Diabetes mellitus, pp. 496-502
[31.]
M.D. Esposti, A. Ngo, M.A. Myers.
Inhibition of mitochondrial complex I may account for IDDM induced by intoxication with rodenticide Vacor.
Diabetes, 45 (1996), pp. 1531-1534
[32.]
M. Solimena, R. Folli, Aparisi, G. Pozza, P. De Camilli.
Autoantibodies to GABA-nergic neurons and pancreatic beta cells in stiffman síndrome.
N Engl J Med, 41 (1992), pp. 347-353
[33.]
B.E. Metzger, Committee Organizing.
Summary and recommendations of the Third International Workshop-Conference on Gestational Diabetes Mellitus.
Diabetes, 40 (1991), pp. 197-201
[34.]
Mellitus The Expert Committee on the Diagnosis and Classification of Diabetes.
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.
Diabetes Care, 20 (1997), pp. 1183-1197
[35.]
The Expert Committe on the Diagnosis and Classification of Diabetes Mellitus.
Diabetes Care, 26 (2003), pp. 5-20
[36.]
M.M. Gabir, R.L. Hanson, D. Dabelea, G. Imperatore, J. Roumain, P.H. Bennett.
The 1997 American Diabetes Association and 1999 World Health Organization Criteria for hyperglycemia in the diagnosis and prediction of diabetes.
Diabetes Care, 23 (2000), pp. 1108-1112
[37.]
B.L. Somani, S.S. Bangar, R. Bhalwar.
American Diabetes Association criteria for diabetes diagnosis.
Diabetes Care, 22 (1999), pp. 366
[38.]
E. Mannucci, A. De Bellis, A.M. Cernigoi, C. Tortul, C.M. Rotella, M. Velussi, et al.
Further data on the comparison between World Health Organization and American Diabetes Association diagnostic criteria.
Diabetes Care, 22 (1999), pp. 1755-1756
[39.]
World Health Organization.
Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation.
Part 1. Diagnosis and classification of diabetes mellitus,
[40.]
Association American Diabetes.
Tests of glycemia in diabetes (Position Statement).
Diabetes Care, 26 (2003), pp. 106-108
[41.]
Association American Diabetes.
Standards of medical cares for patients with diabetes mellitus (Position Statement).
Diabetes Care, 26 (2003), pp. 33-50
[42.]
M. Mayrhofer, D.U. Rabin, L. Messenger, E. Standl, A.G. Ziegler.
Value of ICA 512 antibodies for prediction and diagnosis of type 1 diabetes.
Exp Clin Endocrinol Diab, 104 (1996), pp. 228-234
[43.]
J.P. Krischer, D.D. Cuthbertson, L. Yu, T. Oraban, N. MacLaren, R. Jackson, et al.
Screening strategies for the identificartion of multiple antibody-positive relatives of individuals with type 1 diabetes.
J Endocrinol Metab, 88 (2003), pp. 103-108
[44.]
T. Kimpimäki, P. Kulmala, K. Savola, A. Kupila, S. Korhonen, T. Simell.
Natural history of beta-cell autoinmunity ub young children with increased genetic susceptibility to type 1 diabetes recruited from the general population.
J Clin Endocrinol Metab, 87 (2002), pp. 4572-4579
Copyright © 2003. Elsevier España, S.L.. Todos los derechos reservados
Opciones de artículo
Herramientas
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.